Evaluating the effect of teriflunomide on whole brain atrophy in the phase 3 TOPIC study

被引:0
|
作者
Zivadinov, R. [1 ]
Dwyer, M. G. [1 ]
Carl, E. [1 ]
Thangavelu, K. [2 ]
Cavalier, S. [2 ]
Bergsland, N. [1 ]
机构
[1] SUNY Buffalo, Buffalo, NY USA
[2] Sanofi, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P870
引用
收藏
页码:463 / 463
页数:1
相关论文
共 50 条
  • [41] Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial
    Miller, Aaron E.
    Wolinsky, Jerry S.
    Kappos, Ludwig
    Comi, Giancarlo
    Freedman, Mark S.
    Olsson, Tomas P.
    Bauer, Deborah
    Benamor, Myriam
    Truffinet, Philippe
    O'Connor, Paul W.
    LANCET NEUROLOGY, 2014, 13 (10): : 977 - 986
  • [42] Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis
    Chai, Chao
    Zhang, Mengjie
    Long, Miaomiao
    Chu, Zhiqiang
    Wang, Tong
    Wang, Lijun
    Guo, Yu
    Yan, Shuo
    Haacke, E. Mark
    Shen, Wen
    Xia, Shuang
    METABOLIC BRAIN DISEASE, 2015, 30 (04) : 1009 - 1016
  • [43] Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis
    Chao Chai
    Mengjie Zhang
    Miaomiao Long
    Zhiqiang Chu
    Tong Wang
    Lijun Wang
    Yu Guo
    Shuo Yan
    E. Mark Haacke
    Wen Shen
    Shuang Xia
    Metabolic Brain Disease, 2015, 30 : 1009 - 1016
  • [44] Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy
    Taylor, I
    Butzkueven, H
    Litewka, L
    MacGregor, LR
    Szoeke, C
    Cook, M
    Mitchell, P
    Kilpatrick, TJ
    Tubridy, N
    JOURNAL OF CLINICAL NEUROSCIENCE, 2004, 11 (02) : 153 - 158
  • [45] Whole brain atrophy based on Iterative Principal Component Analysis and MRI techniques in the study of Alzheimer's disease
    Kong, Li
    Huan, Zhongdan
    Reschke, Cole
    Shapiro, Josh
    Liu, Xiaofen
    Ayutyanont, Napatkamon
    Venditti, Justin
    Lee, Wendy
    Reiman, Eric
    Chen, Kewei
    2009 ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, 2009, : 1 - +
  • [46] Long-Term Effect of Teriflunomide in Subgroups Defined by Prior Treatment: Pooled Analysis of the Phase 2 Study and Phase 3 TEMSO, TOWER, and TENERE Core and Extension Studies
    Comi, Giancarlo
    Freedman, Mark
    Meca-Lallana, Jose
    Vermersch, Patrick
    Kim, Byoung Joon
    Parajeles, Alexander
    Edwards, Keith
    Gold, Ralf
    Overell, James
    Korideck, Houari
    Chavin, Jeffrey
    Poole, Elizabeth
    Coyle, Patricia
    NEUROLOGY, 2019, 92 (15)
  • [47] Phase I/II study of IV topotecan in combination with whole brain radiation for the treatment of brain metastases
    Mirmiran, Alireza
    McClay, Edward
    Spear, Matthew A.
    MEDICAL ONCOLOGY, 2007, 24 (02) : 147 - 153
  • [48] Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study
    Minesh P. Mehta
    Ding Wang
    Fen Wang
    Lawrence Kleinberg
    Anthony Brade
    H. Ian Robins
    Aruna Turaka
    Terri Leahy
    Diane Medina
    Hao Xiong
    Nael M. Mostafa
    Martin Dunbar
    Ming Zhu
    Jane Qian
    Kyle Holen
    Vincent Giranda
    Walter J. Curran
    Journal of Neuro-Oncology, 2015, 122 : 409 - 417
  • [49] Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study
    Mehta, Minesh P.
    Wang, Ding
    Wang, Fen
    Kleinberg, Lawrence
    Brade, Anthony
    Robins, H. Ian
    Turaka, Aruna
    Leahy, Terri
    Medina, Diane
    Xiong, Hao
    Mostafa, Nael M.
    Dunbar, Martin
    Zhu, Ming
    Qian, Jane
    Holen, Kyle
    Giranda, Vincent
    Curran, Walter J.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (02) : 409 - 417
  • [50] Efficacy and safety of teriflunomide in Chinese patients with relapsing forms of MS: A subgroup analysis of the phase 3 tower study
    Macdonell, R.
    Freedman, M.
    Xu, X.
    Vucic, S.
    Truffinet, P.
    Benamor, M.
    Thangavelu, K.
    Miller, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 135 - 135